TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of ($0.08), $0.16 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $41.6 million versus the consensus estimate of $34.59 million.
Guidance:
Sees FY'23 revenue of $160 million to $170 Million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.